These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 36539841)

  • 1. Barriers and facilitators of adherence to treatment among women with vulvovaginal candidiasis: a qualitative study.
    Erfaninejad M; Salahshouri A; Amirrajab N
    Eur J Med Res; 2022 Dec; 27(1):303. PubMed ID: 36539841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vulvovaginal candidiasis in Iranian women: Molecular identification and antifungal susceptibility pattern.
    Khaksar Baniasadi A; Ayatollahi Mosavi SA; Sharifi I; Bamorovat M; Salari S; Ahmadi A; Amanizadeh A; Agha Kuchak Afshari S
    J Obstet Gynaecol Res; 2022 Dec; 48(12):3292-3303. PubMed ID: 36184563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct host immune responses in recurrent vulvovaginal candidiasis and vulvovaginal candidiasis.
    Ge G; Yang Z; Li D; Zhang N; Chen B; Shi D
    Front Immunol; 2022; 13():959740. PubMed ID: 35967437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring Iranian β-Thalassemia major patients' perception of barriers and facilitators of adherence to treatment: A qualitative study.
    Emami Zeydi A; Karimi Moonaghi H; Heydari A
    Electron Physician; 2017 Dec; 9(12):6102-6110. PubMed ID: 29560166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of vulvovaginal candidiasis among pregnant women in the Ho municipality, Ghana: species identification and antifungal susceptibility of Candida isolates.
    Waikhom SD; Afeke I; Kwawu GS; Mbroh HK; Osei GY; Louis B; Deku JG; Kasu ES; Mensah P; Agede CY; Dodoo C; Asiamah EA; Tampuori J; Korbuvi J; Opintan JA
    BMC Pregnancy Childbirth; 2020 May; 20(1):266. PubMed ID: 32375724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive review of conventional and non-conventional methods of management of recurrent vulvovaginal candidiasis.
    Watson C; Calabretto H
    Aust N Z J Obstet Gynaecol; 2007 Aug; 47(4):262-72. PubMed ID: 17627679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Relationship Between Vulvovaginal Candidiasis and Provoked Vulvodynia: A Systematic Review.
    Leusink P; van de Pasch S; Teunissen D; Laan ET; Lagro-Janssen AL
    J Sex Med; 2018 Sep; 15(9):1310-1321. PubMed ID: 30145093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vulvovaginal Candidiasis: A Review of the Evidence for the 2021 Centers for Disease Control and Prevention of Sexually Transmitted Infections Treatment Guidelines.
    Nyirjesy P; Brookhart C; Lazenby G; Schwebke J; Sobel JD
    Clin Infect Dis; 2022 Apr; 74(Suppl_2):S162-S168. PubMed ID: 35416967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent vulvovaginal candidiasis.
    Blostein F; Levin-Sparenberg E; Wagner J; Foxman B
    Ann Epidemiol; 2017 Sep; 27(9):575-582.e3. PubMed ID: 28927765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vulvovaginal candidiasis: An overview of mycological, clinical, and immunological aspects.
    Jafarzadeh L; Ranjbar M; Nazari T; Naeimi Eshkaleti M; Aghaei Gharehbolagh S; Sobel JD; Mahmoudi S
    J Obstet Gynaecol Res; 2022 Jul; 48(7):1546-1560. PubMed ID: 35445492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent vulvovaginal candidiasis: A review of guideline recommendations.
    Matheson A; Mazza D
    Aust N Z J Obstet Gynaecol; 2017 Apr; 57(2):139-145. PubMed ID: 28299777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the barriers of adherence to dietary recommendations among patients with type 2 diabetes: A qualitative study in Iran.
    Mostafavi-Darani F; Zamani-Alavijeh F; Mahaki B; Salahshouri A
    Nurs Open; 2020 Nov; 7(6):1735-1745. PubMed ID: 33072357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent vulvovaginal candidiasis - current management.
    Watson C; Pirotta M
    Aust Fam Physician; 2011 Mar; 40(3):149-51. PubMed ID: 21597520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Difference Between the Profiles Presented by Yeasts that Colonize the Vaginal Mucosa or Cause Primary or Recurrent Candidiasis.
    Moreira D; Ruiz LS; Leite-Jr DP; Auler ME; Ramos RTB; Costa VT; Lara BR; Gasparetto A; Gandra RF; Melhem MSC; Paula CR
    Mycopathologia; 2021 Jun; 186(3):411-421. PubMed ID: 34120275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current patient perspectives of vulvovaginal candidiasis: incidence, symptoms, management and post-treatment outcomes.
    Yano J; Sobel JD; Nyirjesy P; Sobel R; Williams VL; Yu Q; Noverr MC; Fidel PL
    BMC Womens Health; 2019 Mar; 19(1):48. PubMed ID: 30925872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment options for vulvovaginal candidiasis, 1993.
    Reef SE; Levine WC; McNeil MM; Fisher-Hoch S; Holmberg SD; Duerr A; Smith D; Sobel JD; Pinner RW
    Clin Infect Dis; 1995 Apr; 20 Suppl 1():S80-90. PubMed ID: 7795112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effects of Ozonated Olive Oil and Clotrimazole Cream for Treatment of Vulvovaginal Candidiasis.
    Tara F; Zand-Kargar Z; Rajabi O; Berenji F; Akhlaghi F; Shakeri MT; Azizi H
    Altern Ther Health Med; 2016 Jul; 22(4):44-9. PubMed ID: 27548492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and Efficacy of a Novel Vaginal Anti-infective, TOL-463, in the Treatment of Bacterial Vaginosis and Vulvovaginal Candidiasis: A Randomized, Single-blind, Phase 2, Controlled Trial.
    Marrazzo JM; Dombrowski JC; Wierzbicki MR; Perlowski C; Pontius A; Dithmer D; Schwebke J
    Clin Infect Dis; 2019 Feb; 68(5):803-809. PubMed ID: 30184181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vulvovaginal candidiasis in reproductive age women in Enugu Nigeria, clinical versus laboratory-assisted diagnosis.
    Aniebue UU; Nwankwo TO; Nwafor MI
    Niger J Clin Pract; 2018 Aug; 21(8):1017-1022. PubMed ID: 30074004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survey of incidence, lifetime prevalence, and treatment of self-reported vulvovaginal candidiasis, United States, 2020.
    Benedict K; Singleton AL; Jackson BR; Molinari NAM
    BMC Womens Health; 2022 May; 22(1):147. PubMed ID: 35538480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.